Welcome to our dedicated page for Aon Plc news (Ticker: AON), a resource for investors and traders seeking the latest updates and insights on Aon Plc stock.
Aon plc reports news about its global professional services business, which combines Risk Capital and Human Capital expertise with analytics, insurance and reinsurance brokerage, and locally delivered client solutions. Recurring updates include earnings releases, organic revenue trends, capital allocation, dividends and guidance tied to its Aon United strategy and 3x3 Plan.
Company announcements also cover insurance capacity programs such as the Data Center Lifecycle Insurance Program, human capital research, compensation data products including the Radford McLagan Compensation Database, technology engagements for reinsurance operations, and leadership changes across regional and enterprise client roles.
Aon plc (NYSE: AON) has announced it will host its Investor Day on June 9, 2025, starting at 8:30 a.m. ET. The event will feature presentations from CEO Greg Case, CFO Edmund Reese, and other senior executives who will discuss the company's 3x3 Plan and how Aon United is positioned to address client needs at the intersection of Risk Capital and Human Capital. The company aims to showcase its strategy for driving sustainable, profitable growth and creating shareholder value. The event will be available via live webcast on Aon's Investor Relations website, with a replay available afterward.
Aon (NYSE: AON) has launched its new Health Price Transparency Analysis, an analytics solution helping U.S. employers gain insights from healthcare pricing data. The tool enables plan sponsors to assess negotiated rates between payers and providers, manage rising medical costs, and make informed decisions about healthcare networks.
The analysis is powered by Aon's team of 300+ health analytics professionals and processes petabytes of public Price Transparency data, covering over 50 million commercial lives, 5,000 hospitals, 600 health systems, and 250 payers. Key features include granular benchmarking, network performance insights, provider price variance analysis, and fiduciary documentation.
According to Aon's 2025 U.S. Health Survey, employers expect healthcare costs to rise 9.2% in 2025, up from 8% in the previous year, highlighting the urgent need for strategic cost management solutions.
Aon has released groundbreaking research on GLP-1 medications and their impact on workforce health, analyzing data from over 50 million commercially insured lives. The study reveals significant cost savings and health improvements when GLP-1s are combined with holistic support programs.
Key findings show that after initial treatment costs, GLP-1 users experienced cost growth rates at half that of the control group. Users saw a 44% reduction in cardiovascular hospitalization risks and improvements in various health conditions over 24 months. The analysis indicates that GLP-1s, paired with wellness programs, can reduce long-term healthcare costs and boost workforce productivity.
In response to these findings, Aon has launched its own subsidized GLP-1 weight management program for U.S. employees in partnership with eMed, offering holistic support including AI-powered biometric tracking and virtual check-ins. This initiative addresses obesity, which affects 40% of U.S. adults and costs the economy up to $1.72 trillion annually.
Aon (NYSE: AON) reported strong Q1 2025 results with 16% total revenue growth reaching $4.7 billion and 5% organic revenue growth. The company's EPS was $4.43, while Adjusted EPS reached $5.67.
Key financial highlights include:
- Risk Capital revenue increased 7% to $3.2 billion
- Human Capital revenue grew 40% to $1.5 billion
- Operating margin decreased to 30.9% from 36.0%
- Adjusted operating income increased 12% to $1.816 billion
The company announced a 10% increase in quarterly dividend, marking the 15th consecutive year of dividend growth. Aon reaffirmed its 2025 guidance, projecting mid-single-digit or greater organic revenue growth, adjusted operating margin expansion, and double-digit free cash flow growth. The company returned $397 million to shareholders through dividends and share repurchases.